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Burkholderia cepacia has emerged as an important cause 
of pulmonary sepsis in individuals with cystic fibrosis 
(CF). Colonization of the airways with this bacterium, 
which often occurs in the second decade of life, is 
associated with three outcomes: chronic asymptomatic 
carriage, progressive deterioration over a prolonged 
period, or a rapidly fatal necrotizing pneumonia [l]. 
Putative virulence factors of B. cepacia remain 
ill-defined, although there is increasing evidence to 
suggest that the bacterium can invade respiratory 
epithelial cells and may thus behave as a facultative 
intracellular pathogen [2,3]. Another member of the 
genus Burkkolderia, B. pseudomallei-the causative agent 
of melioidosis-can also act in this manner [4]. 
Following observations that insulin-dependent 
(type I) diabetes is a risk factor for the development 
of the septicemic form of melioidosis, Woods et a1 
investigated the possibility that insulin may influence 
the growth of B. pseudomallei [5] and reported that 
recombinant human insulin inhibited the growth of 
this bacterium. 
As diabetes is a well-recognized complication of 
CF, we have examined whether a similar interaction 
between B. cepacia and insulin might also occur. More- 
over, our findings, in conjunction with doubts raised 
over the conclusions ofWoods et a1 [6],  suggest that the 
hypothesis that recombinant human insulin affects the 
growth of B. pseudomallei merits re-examination. 
Two strains of B. cepacia were examined. C1359, 
isolated &om a CF patient, was a generous gift from Dr 
J. R. W Govan of the University of Edinburgh Medical 
School, and NCTC 10661, an environmental isolate, 
4 4 0  C l in ica l  M i c r o b i o l o g y  a n d  In fec t ion ,  V o l u m e  5 N u m b e r  7 ,  July  1999 
was obtained &om the National Collection of Type 
Cultures, Central Public Health Laboratory, Colindale, 
UK. In addtion, Pseudomonas aeruginosa PAO-1 was 
used as a control. 
Pharmaceutical-grade preparations of human re- 
combinant and porcine insulins (Velosulin and Human 
Actrapid) and purified human and bovine insulins 
(Sigma, Poole, UK) were employed. 
Strains were incubated overnight in nutrient broth 
in a shaking incubator at either 30°C (as B. cepacia is 
generally recognized as an environmental bacterium) or 
37°C. These cultures were used to inoculate brain- 
heart infusion broth which contained each type of 
insulin at a concentration of 10 IU/mL to give an 
optical density of 0.1 at A600 nm. Controls, in which the 
brain-heart infusion broth contained no insulin, were 
inoculated in the same manner. To further investigate 
whether a putative effect of insulin on growth of B. 
cepacia was concentration dependent, strain C1359 was 
exposed to broth containing human insulin at concen- 
trations of 10, 50 and 100 IU/mL,. Broths with and 
without insulin were incubated at both 3OoC and 
37OC, with optical densities being measured spectro- 
photometrically at regular intervals. All experiments 
were repeated at least once. 
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Inhibitory concentrations of m-cresol for 19 strains 
of B. cepacia of both clinical and environmental origin 
and, in addition, for five strains of B. gladioli and for a 
single strain of Ralstonia (formerly Burkholderia) picketti 
and for l? aeruginosa PA01 and Escherichia coli C600 
were determined using a standard agar dilution method 
[7]. The strains of B. cepacia used were as follows: 
NCTC 10661, NCTC 10743, NCTC 10774 (National 
Collection of Type Cultures, Colindale, UK), NCPPB 
946, NCPPB P945, NCPPB 1962, NCPPB 3025, 
NCPPB 945 (National Collection of Plant Patho- 
genic Bacteria, Harpenden UK), BCE-1 (Laboratory 
Collection, Leeds General Infirmary), and A509, 
A599, C1359, C1524, J23115,J2404 and J2564 (all 
kindly supplied by Dr. J. R. W. Govan, University of 
Edinburgh Medical School, Edinburgh, UK). The B. 
gladioli strains used were NCPPB 644, NCPPB 3263 
and NCPPB 3307 (all National Collection of Plant 
Pathogenic Bacteria, as above). The single Ralstonia 
picketii strain was NCTC 11 149 (National Collection 
of Type Cultures). 
Initial experiments using pharmaceutical-grade 
preparations suggested that both human and porcine 
insulins were able to inhibit the growth of both strains 
of B. cepacia, and of the control strain of l? aeruginosa 
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Figure 1 Growth of Burkholderia cepan'a strain 10661 at 37'C in nutrient broth in the presence (B) and absence (+) of 10 
IU/mL of pharmaceutical-grade recombinant human insulin containing 0.3% (w/v) m-cresol. 
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Figure 2 Growth of Burkholdevia cepacia strain 10661 at 3 7 T  in nutrient broth in the presence (W)  and absence (+) of 10 
IU/mL recombinant human insulin without preservative. 
(results for strain NCTC 10661 are shown in Figure 1). 
However, as m-cresol is used as a preservative in these 
formulations of insulin, experiments were repeated 
using pure crystalline insulin which contained no 
preservative. In these experiments, no inhibition of 
bacterial growth was observed with either human or 
bovine insulin (Figure 2). 
Incubation at 30°C, with both pharmaceutical- 
grade and pure insulins, yielded essentially similar results 
to those experiments carried out a t  37°C (data not 
shown). 
In those experiments where B. cepacia was exposed 
to a range of insulin concentrations, there was no 
significant effect on bacterial growth, although there 
was a trend towards increased growth at the higher 
concentrations, this was only observed on prolonged 
incubation. 
The strains of 3. gladioli, R. picketti, I? aeruginosa 
and E. coli were all inhibited by concentrations of m- 
cresol present in the pharmaceutical preparations of 
insulin (0.3% w/v). Of 19 B. cepacia strains examined, 
three (16%) were capable of growth at concentrations 
in excess of 0.3% w/v of m-cresol. 
Hormones, and their corresponding binding 
proteins, similar to those of vertebrates have been 
identified in a wide range of bacteria, fungi and 
protozoa. For example, Stenotrophomonas maltophilia has 
been shown to elaborate xCG, a protein which has a 
high degree of homology with the P-subunit of human 
chorionic gonadotrophin (hCG) [S]. An autocrine 
and/or paracrine function for xCG has been suggested 
following observations that, when added to growth 
media, it (and hCG) causes changes in the bacterial 
growth cycle and also modifications in cellular morph- 
ology [9]. Furthermore, Le Roith et a1 describe the 
production of insulin, or a molecule which closely 
resembles this hormone, in E. coli [lo]. 
Woods et al noted that type I diabetes mellitus was 
a risk factor for the development of the septiceinic form 
of melioidosis and, accordingly, examined the effect 
of insulin on the growth of the causative bacterium 
B. pseudomallei. They reported that insulin markedly 
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inhibited the growth of this bacterium and cited 
evidence that B. pseudomallei possesses approximately 
5000 specific receptors for insulin on the surface of each 
bacterial cell. They concluded that these findings were 
a possible explanation for the apparent association of 
insulin-dependent diabetes and septicemic melioidosis. 
Infection with another member of the genus Burk- 
hofderia, B. cepada, has emerged as a significant cause of 
morbidity and mortahty in individuals with CE As type 
I diabetes is a common accompanying feature of CF, we 
examined the possibility that insulin might also inhibit 
the growth of B. cepacia. Initial experiments which 
employed pharmaceutical-grade insulin (as had also 
been used by Woods et al [ 5 ] ) ,  appeared to support this 
hypothesis. However, as these preparations frequently 
contain the preservative m-cresol, experiments using 
pure insulins were conducted. These failed to demon- 
strate any inhbition of growth of B. cepacia. Similarly, 
when concentrations of insulin in excess of those 
employed by Woods et al were studied, there was no 
inhibition of growth: in fact, there was a trend for 
increased growth when cultures were incubated for 
24 h, possibly reflecting the ability of the bacterium to 
use insulin as a growth substrate if concentrations are 
sufficiently high. 
We therefore conclude that type I diabetes is 
unlikely to influence the natural history of B. cepacia 
infection in individuals with CE 
Examination of a wider range of strains of B. cepacia 
of both clinical and environmental origin, as well as a 
selection of other species, confirmed that, with the 
exception of three strains of B. cepacia, these were 
inhibited by the concentrations of m-cresol found in 
pharmaceutical preparations of insulin. 
In light of our findings, the hypothesis of Woods 
et al that insulin inhibits the growth of B. pseudomallei 
warrants re-examination in experiments in which 
purified insulin, without preservatives, is employed. 
Additional epidemiologic evidence has also challenged 
the hypothesis of Woods et al. Currie [6] noted that 
although 16 (48%) of 33 cases of melioidosis in Darwin 
in the Northern Territory of Australia in an outbreak 
during 1990-91 occurred in diabetic individuals, only 
one was a type I diabetic. Thus the majority of diabetics 
who developed melioidosis were, in fact, likely to be 
hyperinsulinemic. 
It is interesting to note that, in their experiments, 
Woods et al, included a strain of B. cepacia as a control 
and noted that pharmaceutical-grade insulin did not 
inhibit its growth. This suggests that this particular 
strain may have been non-susceptible to preservatives at 
the concentration employed in this formulation of 
insulin. We also identified three strains of B. cepacia 
which were not inhibited by the preservative m-cresol. 
This is not altogether surprising, as some strains of 
B. cepaciu have been shown to possess a plasmid (TOM) 
which carries gene(s) which encode for cresol degrada- 
tion 1111. Currently, we are examining these strains 
to identifjr whether they possess the TOM, or other 
cresol-degrading plasmids. 
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